Related Experiment Videos
Human tumor suppressor ARF impedes S-phase progression independent of p53
Wendell G Yarbrough1, Mika Bessho, Adam Zanation
1Lineberger Comprehensive Cancer Center, Department of Otolaryngology/Head and Neck Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-3280, USA.
Abstract:
Using alternative reading frames, the human ARF-INK4a locus encodes two unrelated proteins that both function in tumor suppression. p16(INK4a) maintains the retinoblastoma protein in its growth-suppressive state through inhibition of cyclin D-dependent kinase activity, whereas ARF binds with MDM2 and stabilizes p53. The majority of the activity of ARF to date is ascribed to its ability to activate p53, resulting in a G(1) cell cycle arrest or apoptosis. We show here that ARF colocalizes with DNA replication protein A (RPA32) and that overexpression of ARF reduces the rate of DNA synthesis resulting in accumulation of an S-phase cell population. Impediment of DNA synthesis by ARF can occur and becomes more evident in the absence of p53. Hence, the biological consequence of ARF induction varies dependent on cellular p53 status, inducing predominantly a G(1) arrest or apoptosis in p53-positive cells or causing S-phase retardation when p53 function is comprised.
Insights
The ARF tumor suppressor protein impacts cell cycle progression differently based on p53 status. ARF can cause cell cycle arrest or apoptosis in p53-positive cells, but slows DNA synthesis in p53-deficient cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The human ARF-INK4a locus produces two tumor suppressors: p16(INK4a) and ARF.
- ARF typically stabilizes p53, promoting cell cycle arrest or apoptosis.
- ARF's role in DNA synthesis and its dependence on p53 status are not fully understood.
Purpose of the Study:
- To investigate the effect of ARF on DNA synthesis.
- To determine if ARF's impact on DNA synthesis is modulated by p53.
- To elucidate the alternative functions of ARF beyond p53 stabilization.
Main Methods:
- Immunofluorescence to observe ARF and RPA32 colocalization.
- Cell proliferation assays to measure DNA synthesis rates.
- Experiments conducted in both p53-positive and p53-deficient cellular contexts.
Main Results:
- ARF was found to colocalize with DNA replication protein A (RPA32).
- Overexpression of ARF led to reduced DNA synthesis and S-phase accumulation.
- ARF's inhibitory effect on DNA synthesis was more pronounced in the absence of p53.
Conclusions:
- ARF can directly impede DNA synthesis, independent of its canonical p53-mediated functions.
- The cellular outcome of ARF induction (G1 arrest/apoptosis vs. S-phase retardation) is contingent on p53 functional status.
- ARF exhibits context-dependent tumor suppressive mechanisms impacting cell cycle regulation.